CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 312 enrolled
Drug / intervention
Tramadol-ondansetron continuous infusion +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05879536
NCT05879536N/ACompleted
CompareCT.gov

The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section. A Prospective, Observational and Non-inferiority Study Against Epidural Analgesia.

Hospital Universitario La Fe·observational·Posted May 30, 2023·Updated Feb 21, 2025

In Brief

An observational study evaluating Tramadol-ondansetron continuous infusion and Ropivacaine via epidural catheter for Post Operative Pain and 8 related conditions. Completed, enrolled 312 participants across 1 site.

Detailed Summary

It will be a prospective observational cohort study. The investigators will compare post-cesarean section recovery in patients receiving intravenous infusion of tramadol-ondansetron versus epidural catheter with infusion of local anesthetics.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPost Operative Pain, Cesarean Section, Tramadol, Postoperative Recovery, Quality of Recovery, Ondansetron, QoR-15, ObsQor-10, Postcesarean Recovery
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMay 30, 2023
Enrollment StartMay 23, 2023
Primary CompletionOct 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 3.1 years ago

Interventions

Tramadol-ondansetron continuous infusiondrug

Analgesia strategy determined by routine use according to protocols, without investigator intervention.

Ropivacaine via epidural catheterdrug

Analgesia strategy determined by routine use according to protocols, without investigator intervention.